Strength
.1 mg/mL
Manufacturer
Baxter Healthcare CorporationNDC
36000014810
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Last Updated
4/22/2026
Active Ingredients
FLUMAZENILApproval Type
Generic (ANDA)
FDA Application
ANDA076755On Market Since
10/1/2017
Pharmacological Classes
Benzodiazepine Antagonist